Teva Pharmaceutical Industries Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $50.64B
Liabilities Breakdown FY2020
Total Liabilities: $39.58B
Asset Breakdown
Total Assets: $50.64B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.18B | 4.3% |
| Accounts Receivable | $4.58B | 9.0% |
| Inventory | $4.40B | 8.7% |
| Property, Plant & Equipment | $6.30B | 12.4% |
| Goodwill | $20.62B | 40.7% |
| Intangible Assets | $8.92B | 17.6% |
| Other Assets | $3.64B | 7.2% |
Liabilities Breakdown
Total Liabilities: $39.58B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.76B | 4.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.82B | 95.6% |